Albert Frederick CANDIA, III,Richard Thomas BERESIS,Robert L. COFFMAN
申请号：
US16348816
公开号：
US20190345161A1
申请日:
2017.11.09
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to compounds of formula (I): or a salt or solvate thereof, wherein the variables are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are antagonists of toll-like receptors such as TLR7, TLR8 and/or TLR9 that are useful for inhibiting immune response and treating diseases associated with undesirable immune response.
